GlassScriptPhysician profile
Anna L C Clark
NPI 1144657602
$930.02
in general payments reported to CMS, 2019-2025
19 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $150 · 2022: $54.68 · 2023: $280 · 2024: $267 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $120.57 | 2022-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $119.32 | 2021-2025 | |
| Millicent US INC | $104.53 | 2024-2025 | Femring, Intrarosa |
| Abbvie INC. | $75.61 | 2021-2023 | |
| Myriad Women'S Health, INC. | $74.32 | 2023 | Myrisk |
| Sage Therapeutics, LLC | $74.22 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $62.93 | 2022-2024 | Slynd |
| Boston Scientific Corporation | $53.22 | 2023-2024 | Advantage System |
| Coopersurgical, INC. | $40.10 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Sumitomo Pharma America, INC. | $29.57 | 2024-2025 | Myfembree |
| Pfizer INC. | $29.14 | 2021 | |
| Mylan Pharmaceuticals INC. | $24.47 | 2022 | |
| Myovant Sciences INC. | $20.78 | 2021 | |
| Organon LLC | $20.34 | 2024 | |
| Dexcom, INC. | $18.07 | 2025 | Dexcom G6 Transmitter |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $17.40 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $16.43 | 2021 | |
| Evofem Biosciences, INC. | $15.38 | 2023 | Phexxi |
| Outset Medical INC | $13.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.